148 related articles for article (PubMed ID: 23250696)
1. [Biomarker screening for early detection of cancer].
Wiedemann GJ
Dtsch Med Wochenschr; 2013 Jan; 138(1-2):43-5. PubMed ID: 23250696
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer screening and biomarkers.
Brooks M
Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
[TBL] [Abstract][Full Text] [Related]
3. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
4. Biomarker approaches to the development of cancer screening tests: can cancer blood tests become a routine health check-up?
Linkov F; Yurkovetsky Z; Lokshin A
Future Oncol; 2007 Jun; 3(3):295-8. PubMed ID: 17547524
[TBL] [Abstract][Full Text] [Related]
5. A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection.
Sun Z; Fu X; Zhang L; Yang X; Liu F; Hu G
Anticancer Res; 2004; 24(2C):1159-65. PubMed ID: 15154641
[TBL] [Abstract][Full Text] [Related]
6. [Application of tumour markers in clinical practice].
Keuren JF; Thomas CM; Bonfrèr JM; Sweep CG; Boonstra JG
Ned Tijdschr Geneeskd; 2009; 153():A617. PubMed ID: 19857306
[TBL] [Abstract][Full Text] [Related]
7. Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.
Draghici S; Chatterjee M; Tainsky MA
Expert Rev Mol Diagn; 2005 Sep; 5(5):735-43. PubMed ID: 16149876
[TBL] [Abstract][Full Text] [Related]
8. Can cancer be diagnosed with a blood test during routine examinations?
Weiss PA; Weiss PA
Clin J Oncol Nurs; 2007 Dec; 11(6):940-1. PubMed ID: 18063553
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies in cancer: prognostic biomarkers and immune activation.
Järås K; Anderson K
Expert Rev Proteomics; 2011 Oct; 8(5):577-89. PubMed ID: 21999829
[TBL] [Abstract][Full Text] [Related]
10. Decreased serum miR-181a is a potential new tool for breast cancer screening.
Guo LJ; Zhang QY
Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
[TBL] [Abstract][Full Text] [Related]
11. A combination of serum markers for the early detection of colorectal cancer.
Wild N; Andres H; Rollinger W; Krause F; Dilba P; Tacke M; Karl J
Clin Cancer Res; 2010 Dec; 16(24):6111-21. PubMed ID: 20798228
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening.
Crump C; McIntosh MW; Urban N; Anderson G; Karlan BY
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1107-11. PubMed ID: 11045795
[TBL] [Abstract][Full Text] [Related]
13. A review of novel biological tools used in screening for the early detection of lung cancer.
Ghosal R; Kloer P; Lewis KE
Postgrad Med J; 2009 Jul; 85(1005):358-63. PubMed ID: 19581246
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
[TBL] [Abstract][Full Text] [Related]
15. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
[TBL] [Abstract][Full Text] [Related]
16. Solving the overdiagnosis dilemma.
Esserman L; Thompson I
J Natl Cancer Inst; 2010 May; 102(9):582-3. PubMed ID: 20413743
[No Abstract] [Full Text] [Related]
17. [Screening and early diagnosis of cancers: 2 ways for a same goal].
Bourmaud A; Nourissat A; Chauvin F
Rev Prat; 2010 Feb; 60(2):183-8, 190. PubMed ID: 20225552
[TBL] [Abstract][Full Text] [Related]
18. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
[TBL] [Abstract][Full Text] [Related]
19. A step forward for two-step screening for ovarian cancer.
Hensley ML
J Clin Oncol; 2010 May; 28(13):2128-30. PubMed ID: 20368556
[No Abstract] [Full Text] [Related]
20. How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer.
Cordero OJ; De Chiara L; Lemos-González Y; Páez de la Cadena M; Rodríguez-Berrocal FJ
Anticancer Res; 2008; 28(4C):2333-41. PubMed ID: 18751415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
